What Are Systemic Disease Causes of Oral Ulcers?
Discussion Oral ulcers are common problems seen by dentists but pediatricians also see them. Usually families have are concerned because they are painful and acute. Ulcers are sometime noticed by the physician and not the family as in the case of herpangina or hand-foot and mouth disease. Chronic or recurrent ulcerations present less commonly and therefore it may be more difficult to determine their etiology. Many of the systemic disease causes of oral ulcers are overall infrequent and/or not common in the pediatric age range. Ulcers can be classified in several ways but acute ulcers are usually painful and last less tha...
Source: PediatricEducation.org - September 21, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

7 Takeaways From the AGA's New Iron-Deficiency Anemia Guidelines 7 Takeaways From the AGA's New Iron-Deficiency Anemia Guidelines
Dr David Johnson comments on the latest recommendations for the gastrointestinal evaluation of iron-deficiency anemia, which have practice-changing implications.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 18, 2020 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Mosquito Clouds Killing Deer, Cattle In Southwest Louisiana
Swarms of skeeters are biting horses, deer and cattle and leaving them anemic and bleeding under their skins. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - September 12, 2020 Category: Science Source Type: news

Feline leukaemia virus infection: A clinical and epidemiological enigma
(SAGE) Feline leukaemia virus (FeLV) is a gammaretrovirus that occurs worldwide in domestic cats, as well as small wild cats. It is associated with various serious, and sometimes fatal, diseases including anaemia, immunosuppression and certain cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

REALITY Trial Supports Restrictive Transfusion in Anemic MI REALITY Trial Supports Restrictive Transfusion in Anemic MI
A restrictive blood transfusion strategy in myocardial infarction patients with anemia proved safe, significantly less costly, and at least as effective as the standard liberal transfusion strategy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 3, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

South Africa: UCT Professor's Research Offers Hope of Treatment for Sickle Cell Anaemia
[GroundUp] In a study performed in Cameroon, UCT professor Ambroise Wonkam has identified genetic factors which protect some patients from the effects of sickle cell anemia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 2, 2020 Category: African Health Source Type: news

AGA recommends bidirectional endoscopy for most patients with iron deficiency anemia
(American Gastroenterological Association) The American Gastroenterological Association (AGA) published new clinical guidelines outlining an evidence-based approach for the initial gastrointestinal evaluation of chronic iron deficiency anemia in asymptomatic patients. Iron deficiency anemia is extremely common worldwide, and a gastrointestinal cause should be considered in all patients without an obvious cause for their anemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 1, 2020 Category: International Medicine & Public Health Source Type: news

AGA Releases Iron-Deficiency Anemia Guideline AGA Releases Iron-Deficiency Anemia Guideline
The seven recommendations aim to improve quality of care and reduce practice variability.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 26, 2020 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Akebia Therapeutics Announces First Commercial Launch of VAFSEO(TM) (vadadustat tablets), a New Oral Treatment for Anemia Due to Chronic Kidney Disease, in Japan
VAFSEO Launch Marks Availability of Convenient Once-Daily Oral Treatment for Adult Patients on Dialysis and Not on Dialysis in Japan CAMBRIDGE, Mass., Aug. 26, 2020 -- (Healthcare Sales & Marketing Network) -- Akebia Therapeutics®, Inc. (Nasdaq: AK... Biopharmaceuticals, Product Launch Akebia Therapeutics, vadadustat, VAFSEO , chronic kidney disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 26, 2020 Category: Pharmaceuticals Source Type: news

Africa: UCT Sickle Cell Genetics Study a First for Africa
[UCT] New research investigating the genetic modifiers of long-term survival in individuals with sickle cell anaemia (SCA) reveals a range of possible pathways for novel therapeutic interventions. Professor Ambroise Wonkam, principle investigator and director of Genetic Medicine of African Populations (GeneMAP) in the University of Cape Town's (UCT) Division of Human Genetics, says apart from the study's clinical potential, the fact that it is so deeply rooted in Africa also presents the opportunity for a paradi (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 25, 2020 Category: African Health Source Type: news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen ’s Leadership in Novel Treatments for Autoimmune Diseases
NEW BRUNSWICK, N.J., August 19, 2020 – Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease. The transaction will include full global rights to nipocalim...
Source: Johnson and Johnson - August 19, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Study explores the association of malaria, HIV with anemia during pregnancy
(Penn State) Pregnant women from sub-Saharan Africa with malaria and human immunodeficiency virus (HIV) have a higher prevalence of anemia than pregnant women without infections, according to Penn State College of Medicine researchers. The findings may have implications for reducing the risk of death in pregnant women and preventing low birth weights and neurocognitive impairment in their children as a result of anemia. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 14, 2020 Category: Infectious Diseases Source Type: news

What Are Some Pediatric Oncological Emergencies?
Discussion Pediatric cancers in the US number about 12,000 per year. After injury, it is the second leading cause of death in children and adolescents. Cancer presentations vary widely, but often begin with non-specific symptoms that continue or progress depending on the location and tumor type. Patients can present with oncological emergencies especially if there are mechanical obstruction such as superior vena cava syndrome or cerebral herniation. More commonly are infections due to immunosuppression. Cancer treatment also causes its own myriad of problems that clinicians need to be aware of to diagnosis and treat, but a...
Source: PediatricEducation.org - July 20, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Iron deficiency symptoms: Does iron deficiency make you tired
IRON DEFICIENCY ANAEMIA is caused by lack of iron, which usually occurs during pregnancy or when you lose a lot of blood. Does iron deficiency make you tired? (Source: Daily Express - Health)
Source: Daily Express - Health - July 17, 2020 Category: Consumer Health News Source Type: news

Q & A: Understanding COVID-19 ’ s Impact on Food Security and Nutrition
Food markets were closed as many countries across the globe went into a lockdown to prevent the spread of COVID-19. The reduced access to high-value foods and higher food prices for nutritious foods has led to a risk of declining dietary quality globally. Credit: Jorge Luis Baños/IPS By Samira SadequeUNITED NATIONS, Jul 15 2020 (IPS) While it is too early to assess the full impact of the global COVID-19 lockdowns, at least 83 million to 132 million more people may go hungry this year — 690 million people were classified as hungry in 2019 — as the pandemic has highlighted the vulnerabilities and inadequac...
Source: IPS Inter Press Service - Health - July 15, 2020 Category: International Medicine & Public Health Authors: Samira Sadeque Tags: Development & Aid Editors' Choice Featured Food & Agriculture Food Security and Nutrition Food Sustainability Gender Global Headlines Health Humanitarian Emergencies IPS UN: Inside the Glasshouse Population Poverty & SDGs Regio Source Type: news

Vitamin B12 deficiency: Pain felt in either of these two body regions could mean danger
VITAMIN B12 helps prevent a type of anaemia called megaloblastic anaemia which makes a person tired and weak. Pain is another warning sign and if felt on either of these two regions could mean you have a B12 deficiency. (Source: Daily Express - Health)
Source: Daily Express - Health - July 14, 2020 Category: Consumer Health News Source Type: news

Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults), NHS England
Aplastic anaemia is a rare and serious bone marrow failure disorder causing a high risk of life-threatening bleeding and infections, and requiring frequent hospital admissions. Current definitive treatments for aplastic anaemia are stem cell transplant or immunosuppressive therapy with antithymocyte globulin and/or ciclosporin. Stem cell transplant is a procedure in which a patient receives healthy stem cells to replace damaged stem cells. Immunosuppressive treatment is where drugs are given to lower the body's immune response. Stem cell transplant and antithymocyte globulin treatment require hospital admission (Source: Cu...
Source: Current Awareness Service for Health (CASH) - July 14, 2020 Category: Consumer Health News Source Type: news

Using Epo against COVID-19
Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth factor could mitigate severe disease progression and protect patients from long-term neurological effects when the Sars-CoV-2 virus attacks the brain. (Source: World Pharma News)
Source: World Pharma News - July 6, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Rethink Food Security and Nutrition Following Covid-19 Pandemic
By Jomo Kwame Sundaram and Wan Manan MudaKUALA LUMPUR, Malaysia, Jul 2 2020 (IPS) The Covid-19 crisis has had several unexpected effects, including renewed attention to food security concerns. Earlier understandings of food security in terms of production self-sufficiency have given way to importing supplies since late 20th century promotion of trade liberalization. Jomo Kwame SundaramTransnational food business Disruption of transnational food supply chains and the devastation of many vulnerable livelihoods by policy responses to the Covid-19 pandemic have revived interest in earlier understandings of food self-sufficien...
Source: IPS Inter Press Service - Health - July 2, 2020 Category: International Medicine & Public Health Authors: Jomo Kwame Sundaram and Wan Manan Muda Tags: Development & Aid Economy & Trade Food Security and Nutrition Food Sustainability Global Headlines Health Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Source Type: news

Preoperative anaemia measures offer large clinical and economic benefits
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2020 Category: Drugs & Pharmacology Source Type: news

FDA approves Roche ’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer
             Basel, 29 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Phesgo ™, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer. This is the first time that Roche has combined two monoclonal antibodies that can be administered by a single SC i...
Source: Roche Media News - June 29, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer
             Basel, 29 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Phesgo ™, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer. This is the first time that Roche has combined two monoclonal antibodies that can be administered by a single SC i...
Source: Roche Investor Update - June 29, 2020 Category: Pharmaceuticals Source Type: news

Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients
First Regulatory Approval for Akebia's HIF-PHI Marks Beginning of Next Phase of Akebia's Growth Story CAMBRIDGE, Mass., June 29, 2020 -- (Healthcare Sales & Marketing Network) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical compan... Biopharmaceuticals, Regulatory Akebia Therapeutics, vadadustat, chronic kidney disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2020 Category: Pharmaceuticals Source Type: news

His anemia was followed by searing foot pain. Seventeen years later, in precarious shape, a stellar athlete learned what was wrong.
A specialist’s blunt questions exposed the prolonged failure to diagnose and treat an elementary school principal for a disease that could have killed him. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 27, 2020 Category: Consumer Health News Authors: Sandra G. Boodman Source Type: news

Complications After Colonoscopy Up for Those Aged ≥ 75
Other factors associated with risk include anemia, cardiac arrhythmia, hypertension, smoking history, obesity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2020 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Journal, Source Type: news

Things I know to be true 1 – We are all walking miracles
Back when I was child I genuinely believed that when my mother kissed my knee to make it better, she did actually do that. And as I grew older although that belief faded away in the light of the obvious ‘fact’ of the medical model, it never truly disappeared. Time and again I would reflect on what it meant to be healthy and when my own health challenges began in my mid-teens, some part of me always knew that my mother’s kiss held meaning. I remember being 16 years old and just about to sit ‘O’ levels, as they were then. I had been having a period for what must have been weeks and I was tired a...
Source: The Hysterectomy Association - June 25, 2020 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health life miracle Source Type: news

Things I know to be true – We are all walking miracles
Back when I was child I genuinely believed that when my mother kissed my knee to make it better, she did actually do that. And as I grew older although that belief faded away in the light of the obvious ‘fact’ of the medical model, it never truly disappeared. Time and again I would reflect on what it meant to be healthy and when my own health challenges began in my mid-teens, some part of me always knew that my mother’s kiss held meaning. I remember being 16 years old and just about to sit ‘O’ levels, as they were then. I had been having a period for what must have been weeks and I was tired a...
Source: The Hysterectomy Association - June 25, 2020 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health life miracle Source Type: news

Nigeria: Buhari's COVID-19 Economic Plan - Neither Novel Nor Groundbreaking
[The Conversation Africa] COVID-19 is increasingly wreaking havoc on the health of Nigerians, but its economic impact may well be more devastating. Before the pandemic, the Nigerian economy was growing at an anaemic rate of 2%. The country has also been suffering from high poverty and unemployment rates. This is paradoxical for a country endowed with humongous natural resources. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 25, 2020 Category: African Health Source Type: news

Researchers discover improved treatment for children with sickle cell anemia
(Indiana University School of Medicine) A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2020 Category: International Medicine & Public Health Source Type: news

Researchers find best way to treat children with sickle cell anemia in sub-Saharan Africa
(Indiana University) A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2020 Category: International Medicine & Public Health Source Type: news

Tazemetostat Shows Promise for Pleural Mesothelioma
Five different research groups at the American Society of Clinical Oncology annual meeting last month made presentations on the effectiveness of tazemetostat, a novel protein inhibitor, in fighting various cancers. Pleural mesothelioma was one of those cancers in which clear efficacy was demonstrated, raising hopes again for a future second-line therapy option. “It wasn’t the breakthrough you may be looking for, but there is a set of patients now that can benefit from this treatment for a period of time,” Dr. Marianna Koczywas, medical oncologist at City of Hope cancer treatment and research center in Cal...
Source: Asbestos and Mesothelioma News - June 24, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Best way found to treat children with sickle cell anemia in sub-Saharan Africa
(Cincinnati Children's Hospital Medical Center) A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug. They report in the New England Journal of Medicine that the clinical research milestone removes a major barrier to broadly expand the use of hydroxyurea in low-resource regions like sub-Saharan Africa. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2020 Category: Infectious Diseases Source Type: news

New Horizons in Iron Deficiency Anemia in Older Adults New Horizons in Iron Deficiency Anemia in Older Adults
This article reviews the evaluation and assessment of iron deficiency anemia in older adults, focusing on determining the underlying etiology. What's the optimal treatment for this common problem?Age and Ageing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2020 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

The presence of anemia in children with abusive head trauma - Even KM, Subramanian S, Berger RP, Kochanek PM, Zuccoli G, Gaines BA, Fink EL.
OBJECTIVES: To evaluate the incidence of anemia in patients with abusive head trauma (AHT), noninflicted traumatic brain injury (TBI), and physical abuse without AHT and the effect of anemia on outcome. STUDY DESIGN: In a retrospective, single-center c... (Source: SafetyLit)
Source: SafetyLit - June 18, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Vitamin B12 deficiency: Hearing this sound could signal you're lacking the vitamin
VITAMIN B12 deficiency produces a number of eerie effects on the body and the type of symptoms you may experience depend on the underlying cause. One common warning sign associated with B12 deficiency caused by pernicious anaemia is a particular sound. (Source: Daily Express - Health)
Source: Daily Express - Health - June 16, 2020 Category: Consumer Health News Source Type: news

Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020
Basel, 13 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta ®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual Congress Press Briefing on Saturda y 13 June 2020 at 08:30 CEST and will be presented at the congress during the Late-breaking Oral Session (abstract #LB2601) on Sunday 14 June 2020.“We are very pleased to p...
Source: Roche Media News - June 13, 2020 Category: Pharmaceuticals Source Type: news

Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020
Basel, 13 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta ®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual Congress Press Briefing on Saturda y 13 June 2020 at 08:30 CEST and will be presented at the congress during the Late-breaking Oral Session (abstract #LB2601) on Sunday 14 June 2020.“We are very pleased to p...
Source: Roche Investor Update - June 13, 2020 Category: Pharmaceuticals Source Type: news

Vitamin B12 deficiency symptoms: Five surprising ways B12 deficiency can affect the body
VITAMIN B12 aids the body in essential ways yet some people struggle to absorb the vitamin due to an underlying condition called pernicious anaemia. This can raise one's risk of developing B12 deficiency - here are five early warning signs. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2020 Category: Consumer Health News Source Type: news

Iron, Vitamin B12, and Folate Deficiencies Have “Dreadful Consequences,” but Treatments Are Available
Anemia is not a normal consequence of aging — it is an overlooked sign of underlying illness, so the approach should be to evaluate, delineate, and address the cause or causes, said T.S. Dharmarajan, MD, at the Annual Conference of AMDA – The Society for Post-Acute and Long-Term Care Medicine. (Source: Caring for the Ages)
Source: Caring for the Ages - June 1, 2020 Category: Health Management Authors: Christine Kilgore Source Type: news

UTA bioengineer uses NSF grant in novel approach to protein analysis
(University of Texas at Arlington) A University of Texas at Arlington bioengineering researcher will use nanotechnology to detect defective iron-carrying proteins in a patient's blood, which could help explain why these patients have anemia. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 29, 2020 Category: Biology Source Type: news

Gold mining with mercury poses health threats for miles downstream
(Duke University) Small-scale gold mining in the Peruvian Amazon poses a health hazard not only to the miners and communities near where mercury is used to extract gold from ore, but also to downstream communities hundreds of kilometers away where people eat mercury-contaminated river fish as part of their diet. Downstream children under 12 with the highest levels of mercury in their bodies were found to have lost IQ points and become anemic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2020 Category: International Medicine & Public Health Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Vitamin B12 deficiency symptoms: The sign in your vision you could be lacking B12
VITAMIN B12 deficiency is mainly caused by a condition called pernicious anaemia. The autoimmune condition prevents the body from benefiting from the nutrient. And a sign in your vision could indicate you're having trouble absorbing it. (Source: Daily Express - Health)
Source: Daily Express - Health - May 23, 2020 Category: Consumer Health News Source Type: news

Software Provides Noninvasive Hemoglobin Measurement With a Smart Phone Software Provides Noninvasive Hemoglobin Measurement With a Smart Phone
An algorithm that computes hemoglobin levels from a smart phone image of the inner eyelid may help patients with anemia and other disorders avoid trips to healthcare centers for blood draws, a new study suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 22, 2020 Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news

Vitamin B12 deficiency symptoms: The sign when showering that may signal you have it
VITAMIN B12 deficiency is primarily caused by an autoimmune condition called pernicious anaemia. One sign of B12 deficiency caused by pernicious anaemia can be spotted in the shower. (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2020 Category: Consumer Health News Source Type: news

ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
RARITAN, NJ, May 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA® (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.[i] Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program (Abstract #5516) beginning May 29th. ERLEADA® ...
Source: Johnson and Johnson - May 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?
(University of California - Davis Health) Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19. The senicapoc study will assess whether the drug can prevent SARS and lung damage and reduce days spent on a ventilator. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 12, 2020 Category: Infectious Diseases Source Type: news

Vitamin B12 deficiency: Why lack of the vitamin can lead to anaemia
VITAMIN B12 is sourced from what you eat. But, when people don't get enough of it, complications can occur - including anaemia. (Source: Daily Express - Health)
Source: Daily Express - Health - May 6, 2020 Category: Consumer Health News Source Type: news

Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Vadadustat achieved primary efficacy and cardiovascular safety endpoints Clear, consistent top-line data advances plan for vadadustat's New Drug Application and other global regulatory submissions Company to discuss top-line data on its scheduled fir... Biopharmaceuticals Akebia Therapeutics, vadadustat, chronic kidney disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 5, 2020 Category: Pharmaceuticals Source Type: news